Clinical Trials Browser

Interventional × Esophageal Neoplasms × CA-4948 × Clear all

NCT05187182 2026-03-18

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

Phase 1 Recruiting

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms